Jing-Jing Liu

1. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
   2020/07/20 by Feng-Cai Zhu, Fengcai Zhu, Xu-Hua Guan +32 · 10 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #Virus-based gene therapy research